Allurion Technologies Inc (ALUR)
0.705
+0.01
(+1.72%)
USD |
NYSE |
Oct 04, 16:00
0.72
+0.02
(+2.13%)
After-Hours: 20:00
Allurion Technologies SG&A Expense (Annual): 92.88M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.88M |
| December 31, 2022 | 65.77M |
| Date | Value |
|---|---|
| December 31, 2021 | 35.96M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
35.96M
Minimum
2021
92.88M
Maximum
2023
64.87M
Average
65.77M
Median
2022
SG&A Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.06M |
| Retractable Technologies Inc | 20.01M |
| InfuSystems Holdings Inc | 58.03M |
| Xtant Medical Holdings Inc | 64.29M |
| Catheter Precision Inc | 17.12M |